Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (2,460) Arrow Down
Filter Results: (2,460) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (2,460)
    • People  (6)
    • News  (578)
    • Research  (1,758)
    • Events  (11)
    • Multimedia  (14)
  • Faculty Publications  (1,389)

Show Results For

  • All HBS Web  (2,460)
    • People  (6)
    • News  (578)
    • Research  (1,758)
    • Events  (11)
    • Multimedia  (14)
  • Faculty Publications  (1,389)
← Page 77 of 2,460 Results →
  • September 2003
  • Case

Allscripts, Inc.

By: William A. Sahlman and Laurence E. Katz
Describes a set of decisions confronting an entrepreneurial team that is considering taking managerial control of Allscripts, a health care venture. The company has gone through nine rounds of external financing and has changed its business model several times. View Details
Keywords: Business Model; Business or Company Management; Venture Capital; Corporate Entrepreneurship; Health Care and Treatment; Corporate Finance; Health Industry
Citation
Find at Harvard
Related
Sahlman, William A., and Laurence E. Katz. "Allscripts, Inc." Harvard Business School Case 804-053, September 2003.
  • 25 Apr 2014
  • News

Laser focus on medical breakthroughs

created new treatments for serious illnesses. In the 1980s Dr. Krauss saw the potential of a new laser eye surgery device. Her investment in Summit Technologies helped it become the first FDA-approved... View Details
  • 01 Jun 2010
  • News

Health IT at the Bedside

without treatment — and without a clear diagnosis or cause. His chest pain was the result of a blockage of his main coronary artery. As for me, I’ve returned to Washington with... View Details
Keywords: Sachin H. Jain; Ambulatory Health Care Services; Health, Social Assistance; Data Processing, Hosting, and Related Services; Information
  • 16 Aug 2024
  • In Practice

Election 2024: What's at Stake for Business and the Workplace?

Sucher: Dust off that COVID playbook After the June 27 debate between President Joe Biden and former President Donald Trump, 64 percent of 1,024 US workers surveyed reported suffering—or seeing others suffer—poor View Details
Keywords: by Rachel Layne
  • March 2016 (Revised March 2022)
  • Teaching Note

Express Scripts: Promoting Prescription Drug Home Delivery (A) and (B)

By: John Beshears
The pharmacy benefit manager (PBM) sector processes prescription drug claims on behalf of companies that offer a prescription drug benefit to their employees. The case associated with this teaching note follows Bob Nease, chief scientist at Express Scripts, as he... View Details
Keywords: Pharmaceuticals; Prescription Drugs; Pharmacy Benefit Manager; PBM; Healthcare; Behavioral Economics; Choice Architecture; Active Choice; Service Delivery; Decision Choices and Conditions; Consumer Behavior; Distribution Channels; Health Care and Treatment; Service Industry; Pharmaceutical Industry
Citation
Purchase
Related
Beshears, John. "Express Scripts: Promoting Prescription Drug Home Delivery (A) and (B)." Harvard Business School Teaching Note 916-047, March 2016. (Revised March 2022.)
  • May 2021
  • Article

Value-Based Healthcare in Urology: A Collaborative Review

By: Chanan Reitblat, Paul A. Bain, Michael E. Porter, David N. Bernstein, Thomas W. Feeley, Markus Graefen, Santosh Iyer, Matthew J. Resnick, C.J. Stimson, Quoc-Dien Trinh and Boris Gershman
Context:
In response to growing concerns over rising costs and major variation in quality, improving value for patients has been proposed as a fundamentally new strategy for how healthcare should be delivered, measured, and... View Details
Keywords: Value-based Healthcare; Integrated Practice Units; Outcome Measurement; Time-Driven Activity-Based Costing; Health Care and Treatment; Value; Cost Management; Strategy; Outcome or Result; Measurement and Metrics
Citation
Find at Harvard
Related
Reitblat, Chanan, Paul A. Bain, Michael E. Porter, David N. Bernstein, Thomas W. Feeley, Markus Graefen, Santosh Iyer, Matthew J. Resnick, C.J. Stimson, Quoc-Dien Trinh, and Boris Gershman. "Value-Based Healthcare in Urology: A Collaborative Review." European Urology 79, no. 5 (May 2021): 571–585.
  • December 2013 (Revised May 2021)
  • Case

Paul Levy: Confronting a 'Corporate Campaign' (A)

By: James K. Sebenius
Hospital CEO Paul Levy confronts an SEIU unionization drive via a "corporate campaign" aimed at undercutting the hospital's relationships with key internal and external constituencies. Having shepherded one of Boston's top teaching hospitals much of the way through a... View Details
Keywords: Dispute Resolution; Corporate Campaign; Negotiating Campaign; Bargaining; Health Care; Hospitals; Unions; Health Care and Treatment; Negotiation; Strategy; Negotiation Process; Labor Unions; Health Industry; Boston
Citation
Educators
Purchase
Related
Sebenius, James K. "Paul Levy: Confronting a 'Corporate Campaign' (A)." Harvard Business School Case 914-020, December 2013. (Revised May 2021.)
  • April 2017
  • Supplement

Imprimis (C)

By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case is a supplement to Imprimis (A & B). Set in 2015, it first describes Imprimis’s decision to introduce its own line of compounded eye drop medication called LessDrops. The case then examines the moral dilemma faced by CEO Mark Baum, who was struck by the... View Details
Keywords: Health Care and Treatment; Cost; Moral Sensibility; Competitive Strategy; Decision Choices and Conditions; Pharmaceutical Industry; United States
Citation
Purchase
Related
Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (C)." Harvard Business School Supplement 717-497, April 2017.
  • August 2013
  • Course Overview Note

Building Life Science Businesses Fall 2013: Course Outline and Syllabus

By: Richard G. Hamermesh
This Course Outline and Syllabus gives an overview of the Fall 2013 class Building Life Science Businesses. View Details
Keywords: Healthcare Ventures; Entrepreneurial Management; Entrepreneurship; Entrepreneurs; Health Care and Treatment; Health Testing and Trials; Medical Specialties; Health Industry; Biotechnology Industry; Medical Devices and Supplies Industry; Asia; North America; Europe
Citation
Purchase
Related
Hamermesh, Richard G. "Building Life Science Businesses Fall 2013: Course Outline and Syllabus." Harvard Business School Course Overview Note 814-019, August 2013.
  • Article

Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users

By: Ariel Dora Stern, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup and Ernst R. Berndt
Biologic drugs account for a disproportionate share of the increase in pharmaceutical spending in the U.S. and worldwide. Against this backdrop, many look to the expanding market for biosimilars—follow-on products to biologic drugs—as a vehicle for controlling... View Details
Keywords: Pharmaceuticals; Drug Spending; Drug Pricing; Health Care and Treatment; Spending; Price; Markets; Cost Management; United States
Citation
Find at Harvard
Read Now
Purchase
Related
Stern, Ariel Dora, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup, and Ernst R. Berndt. "Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users." Health Affairs 40, no. 6 (June 2021): 989–999.
  • 16 Mar 2010
  • First Look

First Look: March 16

empirical framework, which allows us to separate selection from treatment effects of large shareholders. Individual blockholders tend to hold blocks in public firms located close to where they reside. Using... View Details
Keywords: Martha Lagace
  • May 2016
  • Background Note

Health Systems in the Developing World

By: Kevin Schulman, Muhammed Pate and Gary Carbell
This note offers an approach to the evaluation of health care markets globally. It prepares students with a set of questions about the organization of core elements of the health care system. The organization of these elements can vary across markets and can vary in... View Details
Keywords: Health Care and Treatment; Developing Countries and Economies; Public Sector; Private Sector; Opportunities; Analysis
Citation
Educators
Purchase
Related
Schulman, Kevin, Muhammed Pate, and Gary Carbell. "Health Systems in the Developing World." Harvard Business School Background Note 316-112, May 2016.
  • 12 Nov 2024
  • HBS Case

Inside One Startup's Journey to Break Down Hiring (and Funding) Barriers

Blakeman says. A pitch to the right person at the right time at a bar led to a $100,000 angel investment. Diversifying his business, Blakeman started to work with prisons to put his search tools into the hands View Details
Keywords: by Avery Forman; Employment
  • March 2016
  • Case

Residency Select or J3Personica?

By: William Kerr and Kathryn S. Roloff
Residency Select, LLC provides psychometric assessments for matching medical students to residency programs. After a series of successful pilots, founder Alan Friedman is considering whether to continue developing his offerings in this area, or whether to expand into... View Details
Keywords: Marketplace Matching; Expansion; Higher Education; Entrepreneurship; Health Care and Treatment; Growth and Development Strategy; Service Industry
Citation
Educators
Purchase
Related
Kerr, William, and Kathryn S. Roloff. "Residency Select or J3Personica?" Harvard Business School Case 816-088, March 2016.
  • September 2012 (Revised August 2015)
  • Case

Shanghai Pharmaceuticals

By: Regina E. Herzlinger and Natalie Kindred
Shanghai Pharmaceuticals (SPH), a vertically integrated Chinese pharmaceutical conglomerate, was considering its strategic options in the context of a rapidly evolving industry, policy, and economic environment. The company—essentially a collection of subsidiaries... View Details
Keywords: Business Subsidiaries; Business Conglomerates; Vertical Integration; Decision Choices and Conditions; Mergers and Acquisitions; Consolidation; Health Care and Treatment; Global Strategy; State Ownership; Pharmaceutical Industry; Health Industry; Shanghai; United States; Europe
Citation
Educators
Purchase
Related
Herzlinger, Regina E., and Natalie Kindred. "Shanghai Pharmaceuticals." Harvard Business School Case 313-016, September 2012. (Revised August 2015.)
  • February 2022
  • Case

Cleveland Clinic Abu Dhabi (Abridged)

By: Linda A. Hill and Emily Tedards
In 2006, the Cleveland Clinic and Mubadala Investment Company partnered with a bold ambition to deliver world class healthcare in the United Arab Emirates. In 2015, after nearly a decade of planning and construction, Cleveland Clinic Abu Dhabi opened its doors. By... View Details
Keywords: Organization Behavior; Culture; Alignment; Organizational Effectiveness; Purpose; Impact; Leadership Development; Diversity; Collaboration; Co-creation; Learning Organizations; Empowerment; Teams; Team Dynamics; Teamwork; Team Effectiveness; Trust; Talent; Talent Development And Retention; Psychological Safety; Organizational Evolution; Coaching; Board; Analytics; Innovation; Data; Data Visualization; Digital Technology; Digital; Customer Experience; Experimentation; Change Management; Data-driven Decision-making; Debates; Ecosystem; Partnership; Telemedicine; Sustainability; Global Organizations; Local; Hospital; Healthcare; United Arab Emirates; Health Care and Treatment; Partners and Partnerships; Globalization; Quality; Organizational Culture; Mission and Purpose; Innovation and Management; Information Technology; Joint Ventures; Leadership; Performance Effectiveness; Abu Dhabi; United Arab Emirates
Citation
Educators
Purchase
Related
Hill, Linda A., and Emily Tedards. "Cleveland Clinic Abu Dhabi (Abridged)." Harvard Business School Case 422-056, February 2022.
  • August 2012 (Revised December 2023)
  • Background Note

Note on Health Insurance Coverage, Coding, and Payment

By: Regina E. Herzlinger and Jo Ellen Slurzberg
This note explains how health care technology and service innovators receive payment from government insurers, in the U.S. and abroad, and from private insurers. It describes each of the three steps needed to obtain reimbursement: coverage, coding, and payment. It also... View Details
Keywords: Health Care Delivery; Health Care Costs; Health Insurance; Health Insurance Marketplaces; Health Care and Treatment; Cost; Insurance; Innovation and Invention; Private Sector; Public Sector; Decision Making; Information Technology; Health Industry; Insurance Industry
Citation
Educators
Related
Herzlinger, Regina E., and Jo Ellen Slurzberg. "Note on Health Insurance Coverage, Coding, and Payment." Harvard Business School Background Note 313-042, August 2012. (Revised December 2023.)
  • Article

Supporting Value-Based Health Care—Aligning Financial and Legal Accountability

By: Mark M. Zaki, Anupam B. Jena and Amitabh Chandra
U.S. health care payment and delivery-system reforms have focused on improving care by making organizations accountable for outcomes, quality, and costs. Payers have supported the implementation of accountable care organizations (ACOs), bundled-payment models, and... View Details
Keywords: Value-based Health Care; Accountability; Health Care and Treatment; United States
Citation
Find at Harvard
Register to Read
Related
Zaki, Mark M., Anupam B. Jena, and Amitabh Chandra. "Supporting Value-Based Health Care—Aligning Financial and Legal Accountability." New England Journal of Medicine 385, no. 11 (September 9, 2021): 965–967.
  • December 2004 (Revised March 2007)
  • Case

Cutlass Capital, L.P.

By: Richard G. Hamermesh and Brian DeLacey
David Hetz and Jon Osgood are forming a new venture capital fund in 2001 to invest in health care start-ups. Describes their fundraising activities at a time when venture capital investing has reached an all-time high. Although their background skills and experiences... View Details
Keywords: Venture Capital; Negotiation Process; Entrepreneurship; Investment Funds; Health Care and Treatment; Business Startups; Health Industry; United States
Citation
Educators
Purchase
Related
Hamermesh, Richard G., and Brian DeLacey. "Cutlass Capital, L.P." Harvard Business School Case 805-075, December 2004. (Revised March 2007.)
  • July 2020
  • Case

King's College Hospital in Crisis

By: John R. Wells and Benjamin Weinstock
On December 11, 2017, King’s College Hospital NHS Foundation Trust (King’s), one of London’s leading teaching hospital groups, was put into “special measures” by NHS Improvement (NHSI), the financial regulator of England’s National Health Service (NHS). The future of... View Details
Keywords: Hospitals; Financing; Health Care and Treatment; Financial Condition; Crisis Management; Organizational Structure; Transformation; Strategic Planning; United Kingdom
Citation
Educators
Purchase
Related
Wells, John R., and Benjamin Weinstock. "King's College Hospital in Crisis." Harvard Business School Case 721-356, July 2020.
  • ←
  • 77
  • 78
  • …
  • 122
  • 123
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.